Stockscreener 앱 받기
58.60
0.07%
0.04
시간 외 거래:
58.60
Royalty Pharma Plc 주식(RPRX)의 최신 뉴스
Royalty Pharma (RPRX) Following Mixed Earnings Still Looks Close To Fair Value - Sahm
Royalty Pharma plc (RPRX) vs. AstraZeneca PLC (AZN): Which Biopharma Model Offers the Better Growth Story? - Yahoo Finance
Royalty Pharma (RPRX) holder TPC RP EPA1 LLC eyes 11,002-share stock sale - Stock Titan
Royalty Pharma Locks in $100M Zealand Pharma Funding Pact for Blood Disorder Drug - Benzinga
Royalty Pharma (RPRX) Crossed Above the 20-Day Moving Average: What That Means for Investors - Yahoo Finance
Royalty Pharma (NASDAQ:RPRX) Hits Perfect Technical Rating with Breakout Setup - ChartMill
Royalty Pharma (RPRX) files to potentially sell 11.9M Class A shares - Stock Titan
RPRX (RPRX) investor files to sell 125,000 Class A shares on NASDAQ - Stock Titan
Zealand gains $100M in funding from Royalty Pharma (RPRX:NASDAQ) - Seeking Alpha
Zealand Pharma sells rusfertide royalty rights for $100 million - Investing.com
Zealand Pharma sells rusfertide royalty rights for $100 million By Investing.com - Investing.com UK
Behavioral Patterns of RPRX and Institutional Flows - Stock Traders Daily
Royalty Pharma plc and Zealand Pharma A/S Enter into Rusfertide Funding Agreement for $100 Million - marketscreener.com
Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide - The Manila Times
Zealand Pharma enters into a USD 100 million royalty - GlobeNewswire
Royalty Pharma PLC (NASDAQ:RPRX) Plans Quarterly Dividend of $0.23 - MarketBeat
Royalty Pharma (RPRX) Q2 2026 Earnings Call Transcript - AOL.com
Royalty Pharma PLC $RPRX Shares Sold by Wedge Capital Management L L P NC - MarketBeat
Royalty Pharma PLC $RPRX Stake Boosted by Handelsbanken Fonder AB - MarketBeat
Royalty Pharma publishes transcript of Q2 2026 financial results call - Bitget
How Royalty Pharma’s Stronger H1 2026 Earnings and New Academic Focus At Royalty Pharma (RPRX) Has Changed Its Investment Story - simplywall.st
Should Income Investors Look At Royalty Pharma plc (NASDAQ:RPRX) Before Its Ex-Dividend? - simplywall.st
A3LZUK Bond Profile — Key Metrics - TradingView
A3LZUK Bond Coupon Profile — Rate & Payments - TradingView
Royal Bank of Canada Purchases 23,479 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma (RPRX) Institutional Ownership 2026 - MarketBeat
RPHC5824520 Bond Risk Profile - TradingView
Royalty Pharma (NASDAQ:RPRX) Lowered to "Buy" Rating by Wall Street Zen - MarketBeat
Royalty Pharma (RPRX) CEO gets share award and gifts partnership interests - Stock Titan
Royalty Pharma plc (RPRX) CFO logs equity award and 18,500-share gift - Stock Titan
Royalty Pharma (NASDAQ: RPRX) EVP gets 11,002-share Class A equity award - Stock Titan
Royalty Pharma (RPRX) EVP gets 8,252 shares, gifts LP interests - Stock Titan
Royalty Pharma plc (RPRX) Stock Forecasts - Yahoo! Finance Canada
JPMorgan Chase & Co. Issues Positive Forecast for Royalty Pharma (NASDAQ:RPRX) Stock Price - MarketBeat
Royalty Pharma PLC (RPRX) Stock News Today - TradingKey
Bank of America Corp DE Buys 786,921 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma (NASDAQ:RPRX) Announces Earnings Results, Misses Expectations By $1.23 EPS - MarketBeat
Royalty Pharma Q2 2026 slides: guidance raised on strong growth - Investing.com
Royalty Pharma Q2 Earnings Call Highlights - MarketBeat
Royalty Pharma PLC (RPRX) (Q2 2026) Earnings Call Highlights: Strong Growth and Raised Guidance - Yahoo Finance
BofA raises Royalty Pharma stock price target on strong results By Investing.com - Investing.com South Africa
BofA raises Royalty Pharma stock price target on strong results - Investing.com
Earnings call transcript: Royalty Pharma lifts 2026 outlook in strong Q2 - Investing.com
Royalty Pharma plc 2026 Q2ResultsEarnings Call Presentation (NASDAQ:RPRX) 2026-08-05 - Seeking Alpha
Royalty Pharma PLC reports results for the quarter ended June 30Earnings Summary - TradingView
Royalty Pharma (RPRX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Royalty Pharma plc 2026: Revenue $674.14M, EPS $0.04— 10-Q Summary - TradingView
Royalty Pharma (Nasdaq: RPRX) lifts H1 2026 cash flow and profit - Stock Titan
Royalty Pharma (RPRX) Tops Q2 Earnings and Revenue Estimates - Yahoo Finance
Royalty Pharma Q2 Net Income Falls, Revenue Rises - marketscreener.com
Royalty Pharma reports Q2 2026: Portfolio Receipts $773M, Royalty Receipts up 14% - TradingView
Earnings Flash (RPRX) Royalty Pharma plc Reports Q2 Revenue $674.0M - marketscreener.com
Royalty Pharma raises 2026 receipts outlook to $3.4B-$3.5B - Stock Titan
Cooper Investors PTY Ltd. Has $9.21 Million Stock Position in Royalty Pharma PLC $RPRX - MarketBeat
Lazard Asset Management LLC Sells 108,947 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma: At The Right P/E, I'm In (But Not Here) (NASDAQ:RPRX) - Seeking Alpha
Royalty Pharma Reports Strong Q2 2026 Earnings with Growth Guidance Increase - Intellectia AI
Royalty Pharma earnings in spotlight as revenue dips from Q1 - Investing.com
Royalty Pharma earnings in spotlight as revenue dips from Q1 By Investing.com - Investing.com Nigeria
Gear Up for Royalty Pharma (RPRX) Q2 Earnings: Wall Street Estimates for Key Metrics - Yahoo Finance
Pacer Advisors Inc. Lowers Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Investment Update (And Future Idea): Royalty Pharma PLC (NASDAQ:RPRX) - Seeking Alpha
Eastern Bank Has $38.96 Million Position in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma plc Announces Appointment of Greg Raskin as Senior Vice President, Head of Academic Initiatives, Effective August 2026 - marketscreener.com
Royalty Pharma Appoints Greg Raskin to Lead Academic Partnerships - citybiz
Royalty Pharma appoints Greg Raskin to lead academic outreach - Investing.com
Royalty Pharma appoints Greg Raskin to lead academic outreach By Investing.com - Investing.com South Africa
Royalty Pharma appoints Greg Raskin as Senior Vice President, Head of Academic Initiatives - The Manila Times
Press Release: Royalty Pharma Appoints Greg Raskin as Senior Vice President, Head of Academic Initiatives - Moomoo
The Manufacturers Life Insurance Company Buys 219,772 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma plc (RPRX) Stock Analysis: Exploring Growth and Dividend Potential in Biotech - DirectorsTalk Interviews
Dimensional Fund Advisors LP Has $51.67 Million Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Edgestream Partners L.P. Sells 37,986 Shares of Royalty Pharma PLC $RPRX - MarketBeat
0.22%
0.37%
자본화:
|
볼륨(24시간):